These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 30067166
21. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital. Rojo-Bezares B, Cavalié L, Dubois D, Oswald E, Torres C, Sáenz Y. J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942 [Abstract] [Full Text] [Related]
22. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream. Najar Peerayeh S, Pirhajati Mahabadi R, Pakbaten Toupkanlou S, Siadat SD. Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132 [Abstract] [Full Text] [Related]
23. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital. Çekin ZK, Dabos L, Malkoçoğlu G, Fortineau N, Bayraktar B, Iorga BI, Naas T, Aktaş E. Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808 [Abstract] [Full Text] [Related]
25. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH, Kwon GC, Kim S, Koo SH. J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [Abstract] [Full Text] [Related]
26. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2. PÉrez-VÁzquez M, Sola-Campoy PJ, Zurita ÁM, Ávila A, GÓmez-Bertomeu F, SolÍs S, LÓpez-Urrutia L, GÓnzalez-BarberÁ EM, Cercenado E, Bautista V, Lara N, Aracil B, Oliver A, Campos J, Oteo-Iglesias J, Spanish Antibiotic Resistance Surveillance Program collaborating Group. Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200 [Abstract] [Full Text] [Related]
27. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Edelstein MV, Skleenova EN, Shevchenko OV, D'souza JW, Tapalski DV, Azizov IS, Sukhorukova MV, Pavlukov RA, Kozlov RS, Toleman MA, Walsh TR. Lancet Infect Dis; 2013 Oct; 13(10):867-76. PubMed ID: 23845533 [Abstract] [Full Text] [Related]
28. Presence of blaPER-1 and blaVEB-1 beta-lactamase genes among isolates of Pseudomonas aeruginosa from South West of Iran. Davodian E, Sadeghifard N, Ghasemian A, Noorbakhsh S. J Epidemiol Glob Health; 2016 Sep; 6(3):211-3. PubMed ID: 26944896 [Abstract] [Full Text] [Related]
30. Detection of Metallo-β-Lactamase Producing Pseudomonas aeruginosa Isolated from Public and Private Hospitals in Baghdad, Iraq. Al-Charrakh AH, Al-Awadi SJ, Mohammed AS. Acta Med Iran; 2016 Feb; 54(2):107-13. PubMed ID: 26997597 [Abstract] [Full Text] [Related]
31. [Integron diversity in blavim-2-carrying carbapenem-resistant clinical Pseudomonas aeruginosa isolates]. Savinova TA, Bocharova YA, Lazareva AV, Chebotar IV, Mayanskiy NA. Klin Lab Diagn; 2019 Feb; 64(8):497-502. PubMed ID: 31479607 [Abstract] [Full Text] [Related]
32. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates. Lin SP, Liu MF, Lin CF, Shi ZY. J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695 [Abstract] [Full Text] [Related]
34. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region. Zowawi HM, Syrmis MW, Kidd TJ, Balkhy HH, Walsh TR, Al Johani SM, Al Jindan RY, Alfaresi M, Ibrahim E, Al-Jardani A, Al Salman J, Dashti AA, Sidjabat HE, Baz O, Trembizki E, Whiley DM, Paterson DL. J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716 [Abstract] [Full Text] [Related]
35. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil. Martins AF, Zavascki AP, Gaspareto PB, Barth AL. Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208 [Abstract] [Full Text] [Related]
36. Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in central Pakistan. Saleem S, Bokhari H. J Infect Public Health; 2020 Apr; 13(4):598-605. PubMed ID: 31564530 [Abstract] [Full Text] [Related]
38. Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Mustafa MH, Chalhoub H, Denis O, Deplano A, Vergison A, Rodriguez-Villalobos H, Tunney MM, Elborn JS, Kahl BC, Traore H, Vanderbist F, Tulkens PM, Van Bambeke F. Antimicrob Agents Chemother; 2016 Nov; 60(11):6735-6741. PubMed ID: 27572406 [Abstract] [Full Text] [Related]
39. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A. Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376 [Abstract] [Full Text] [Related]
40. Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran. Shahin M, Ahmadi A. Ann Clin Microbiol Antimicrob; 2021 Nov 03; 20(1):76. PubMed ID: 34732199 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]